Primary immature mediastinal teratoma is very rare. The prognosis of t
his tumour observed in the late teens or adulthood was thought to be v
ery poor. However, recent advances in chemotherapy have improved the p
rognosis. Eleven patients >15 years of age with immature mediastinal t
eratoma (two of our patients and nine from the literature) were review
ed. These patients mere classified into survivor and non-survivor grou
ps, and the characteristics in each group were evaluated. In the survi
vor group, the tumour was completely resected in ail patients. In addi
tion, patients showing a high level of alpha-fetoprotein mere treated
by pre-operative chemotherapy, and those who mere pre-operatively nega
tive for tumour markers were treated by post-operative chemotherapy an
d survived for a long period. All patients in whom the tumour was rese
cted incompletely, or where no chemotherapy was performed, were includ
ed in the non-survivor group. In patients >15 years of age with immatu
re mediastinal teratoma, complete surgical resection of the tumour is
indispensable. When complete resection is combined with chemotherapy,
long survival can be expected. Conversely, unless both treatment metho
ds are performed, the outcome is very poor.